Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Medicine|May 11, 2023
Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndromeMax Augustin, Ferdinand Heyn, Stella Ullrich, et al.
Iscience|October 23, 2023
Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trialVincent Rathkolb, Marianna T Traugott, Andreas Heinzel, et al.
Trials|May 18, 2021
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trialVerena Keitel, Björn Jensen, Torsten Feldt, et al.
Mucosal Immunology|March 7, 2026
Persistent Gut-Immune Axis dysregulation in long-term Post-COVID Syndrome: Insights from a prospective, observational, cross-sectional case-control studyMax Augustin, Lea Picard, Dominic Rauschning, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 7, 2024
Genomic surveillance of SARS-CoV-2 evolution by a centralised pipeline and weekly focused sequencing, Austria, January 2021 to March 2023Olga Frank, David Acitores Balboa, Maria Novatchkova, et al.
Scientific Reports|November 23, 2022
The systemic renin-angiotensin system in COVID-19Roman Reindl-Schwaighofer, Sebastian Hödlmoser, Oliver Domenig, et al.
Journal of Autoimmunity|October 12, 2023
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patientsChrista Lichtensteiger, Maximilian Koblischke, Fiamma Berner, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2022
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External ValidationStefan Heber, David Pereyra, Waltraud C Schrottmaier, et al.
The Lancet. Digital Health|September 3, 2022
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort studyJan A Staessen, Ralph Wendt, Yu-Ling Yu, et al.
Pageof 9